Can a new governor, an oligarch from the region, restore calm in the face of a depressed economy, corruption, and a pro-Russian political establishment?
Lamborghini, Ferrari, Maserati, McLaren, and Porsche are all popular among the filthy rich
The U.S. provides hope that much of the world could eventually avoid both malnutrition and excess nutrition
Microsoft's Xbox One sales need a big boost from exclusive game Titanfall
Comcast might please shareholders by spinning off some 3 million subscribers. How long could the new cable company survive independently?
Groups representing professional photographers prefer to develop ways to pay image creators in place of Getty's tolerance for Web embedding
DIsney's MyMagic+ technology may make a trip to Disney World more magical—or creep customers out
European MBA programs compete with top-tier U.S. schools for the best students at home and abroad
Research suggests that women may turn to entrepreneurship after 50 to support themselves in retirement
San Mateo, Calif.
Founders: Dr. Michael Selley, Dr. Lawrence Steinman, and Dr. Marc Feldmann
VC Investment over the last four quarters: $27 million
Founded in Australia in 2005 and established in the U.S. in 2007, Nuon Therapeutics is a clinical stage company developing oral treatments for multiple sclerosis and rheumatoid arthritis. The six-employee firm, which had previously raised a $5 million Series A round, is continuing development while conserving cash during the downturn, says CEO Rodney Pearlman. "Since we are in clinical stage development, this can be an expensive phase, so we have to ensure we meet our goals while being fiscally responsive to the current environment," he says.
Key to startup success: "Be opportunistic and think outside the box."